About 200 reports

  • 2.4.3 LYSOSOMAL STORAGE DISEASE

LSDs are a family of over ## diverse diseases related by their molecular pathology.

  • Neurological Disorder
  • World
  • Market Size
  • Alexion Pharmaceuticals, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • ELECTROENCEPHALOGRAPHY GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2015-2023) ($MN)

For single channel EEG recordings, three electrodes are needed one active, one reference and one ground. ##-channel device are implemented to perform tasks like EEG screening studies in case the neoplasm or cerebrovascular pathology, in suspected cerebral function monitoring (aEEG) and brain

  • Neurological Disorder
  • World
  • Market Size
  • Compumedics Limited
  • Medtronic, Inc.

While the exact disease pathology is not fully understood, it is known that the symptoms largely result from reduced levels of a neurotransmitter called dopamine in the brain.

  • Neurological Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) Therapeutics Clinical Trials Market,

Pathology; Hepatology Associate Professor ##-##-## Ile de France Location(s)/ Sponsor(s) Sponsor(s)/ Collaborator(s) - Type & Details Sponsor Collaborator(s) Location (s) - Details (##) Region Contact Number State France Co-Author France Co-Author Role Board Certification As

  • Neurological Disorder
  • World
  • Aldagen, Inc.
  • Asklepion Pharmaceuticals, LLC
  • Nutra Pharma Corporation

Laboratories performing genetic tests can be accredited through the Clinical Pathology Accreditation UK Ltd scheme.

  • Neurological Disorder
  • World
  • Forecast
  • Cepheid
  • Transgenomic, Inc.
  • 12.1 BIBLIOGRAPHY

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE; ##(##): ##-##.

  • Neurological Disorder
  • Asia
  • Japan
  • Eisai Co., Ltd.
  • GW Pharmaceuticals plc

ITALY FIGURE ## advances applied to biology, have permitted an ever-increasing number of sophisticated and inventive solutions to properly counter and overcome disablements, handicaps, and pathologies that were once considered to be incurable, and hence there is an increasing demand for med

  • Neurological Disorder
  • World
  • Biotronik SE & Co.
  • Boston Scientific Corporation
  • Cochlear Limited

The strategies for the treatment of other lysosomal storage disorders cannot help in the treatment of Krabbe disease due to the absence of accumulated primary substrate within the lysosome as well as the predominant CNS pathology.

  • Neurological Disorder
  • World
  • Market Size
  • GlaxoSmithKline plc
  • Novartis AG
  • ICP devices

Its continuous monitoring allows early detection of new-onset intracranial hypertension from new pathologies such as repeated bleeding.

  • Neurological Disorder
  • Compumedics Limited
  • Medtronic, Inc.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • 3.1 US Tardive Dyskinesia Market: An Analysis
  • US Tardive Dyskinesia Market by Number of Patients; 2016-2020 ('000)

However, due to unusual pathology related to tardive dyskinesia, the disease is underdiagnosed and represents a much larger population than is estimated.

  • Mental Health
  • Neurological Disorder
  • United States
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International, Inc.

THE AMERICAN JOURNAL OF PATHOLOGY; ##(##): 2068-2076.

  • Neurological Disorder
  • World
  • Forecast
  • Biogen Idec Inc.
  • Novartis AG

The company focuses on developing novel therapies for urological pathologies with a focus on uro-oncology.

  • Neurological Disorder
  • Allergan plc
  • Galderma S.A.
  • Ipsen S.A.
  • Merz Pharmaceuticals GmbH

Histopathological advancements help to monitor the slow progression of the disease, continuum of pathology and in decision making for the required specific biomarkers depending on the progress of AD.

  • Neurological Disorder
  • United States
  • Market Size
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • Teva Pharmaceutical Industries Limited - Recent Pipeline Updates

The mechanism of action of laquinimod has not been fully elucidated, but a study published in the January 2012 issue of The American Journal of Pathology suggests that laquinimod triggers immune cells within the central nervous system to produce and release brainderived neurotrophic factor

  • Neurological Disorder
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

Studies on children are beginning to show interesting functional pathology in autism spectrum disorder, cerebral palsy, epilepsy and other types of neurological and other psychiatric disorders (Down syndrome, traumatic brain injury, Tourette syndrome, lack of hearing, childhood migraine).

  • Neurological Disorder
  • World
  • Covidien plc
  • Medtronic, Inc.
  • Nihon Kohden Corporation
  • 3 Disease Overview

Brain Pathology (Zurich, Brusa L, et al. (2009).

  • Neurological Disorder
  • Japan
  • GlobalData's company
  • Huntington Study Group
  • Pfizer Inc.

In patients with diagnosed cerebrovascular pathologies such as AVMs, intracranial aneurysms, and high-grade symptomatic carotid stenosis, preventive therapy includes their repair or eradication when technically possible.

  • Neurological Disorder
  • United States
  • Forecast
  • GE Healthcare Limited
  • Stryker Corporation

The standardizations for automated quantitation are being enabled though the proprietary image analysis platform and digital pathology capabilities developed by Flagship Biosciences.

  • Neurological Disorder
  • BioMarin Pharmaceutical
  • Lilly Endowment Inc.
  • PTC Therapeutics, Inc.
  • Santhera Pharmaceuticals Holding AG
  • 5.1 BIBLIOGRAPHY

The American Journal of Pathology; ##(##): 2068-2076.

  • Neurological Disorder
  • Biogen Idec Inc.
  • Novartis AG
  • Roche Group
  • Sanofi S.A.
  • 3.4.1 SOURCES USED

pathology services and contacting all general practitioners, pediatricians, and neurology specialists and asking them to report the cases of myasthenia gravis that they were currently treating (Guidetti et al., 1998).

  • Neurological Disorder
  • Japan
  • United States
  • World
  • Forecast

THE ALTERNATIVE COMPLEMENT PATHWAY MIGHT HAVE A ROLE IN MUSK MYASTHENIA, BUT OVERALL THE SIGNIFICANCE FOR PATHOLOGY REMAINS UNCERTAIN.

  • Neurological Disorder
  • Alexion Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • GlobalData's company
  • Roche Group
  • MOLECULAR DIAGNOSTIC TEST - MULTIPLE SCLEROSIS - PRODUCT STATUS
  • RAMBAM HEALTH CARE CAMPUS PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW

It develops therapeutics for nervous system pathologies involving human endogenous retroviruses.

  • Autoimmune Disease
  • Clinical Trial
  • Neurological Disorder
  • United States
  • GlobalData's company
  • parties expect the transaction to close mid-2016.
  • CSL LTD

It develops therapeutics for nervous system pathologies involving human endogenous retroviruses.

  • Neurological Disorder
  • Therapy
  • United States
  • World
  • Product Initiative
  • CLASSIFICATION OF PRIMARY AND SECONDARY TAUOPATHIES
  • 3.2.2 Pathological Classification
  • Clinical Trial
  • Neurological Disorder
  • Therapy
  • Company Operations
  • TauRx Therapeutics Ltd

pathology No Date Parties Stage Value US$m Subject Contract Source: Current Agreements, 2017 ADVANCED RESEARCH ASSOCIATES AEGIS ANALYTICAL AETNA AFFYMETRIX AGENDIA DATE PARTIES STAGE VALUE US$M SUBJECT CONTRACT May 2011 Agendia, AstraZeneca, Netherlands Cancer Institute RESEARCH AGREEMENT F

  • Bioinformatic
  • Clinical Trial
  • Neurological Disorder
  • R&D
  • Medidata
  • Mental Health
  • Neurological Disorder
  • Therapy
  • World
  • AndroScience Corporation, Inc
  • JAN 30, 2017: UCLA WILL LEAD $21 MILLION, GRANT-FUNDED STUDY OF EPILEPSY AFTER TRAUMATIC BRAIN INJURIES

The investigators will collaborate in the fields of bioinformatics, molecular biology, cellular pathology, therapy discovery and the health sciences.

  • Cell Therapy
  • Neurological Disorder
  • Therapy
  • United States
  • GlobalData's company
  • 4.4.3 Multiple Sclerosis
  • Neurodegenerative Disease, Global, Pipeline by Key Indications and Molecule Type, 2017

Pathology is dependent on the affected brain areas.

  • Dementia
  • Neurological Disorder
  • World
  • Deals & Alliance
  • Biogen Idec Inc.
  • The University of New South Wales
  • Mental Health
  • Neurological Disorder
  • World
  • Product Initiative
  • Pfizer Inc.

BECAUSE OF THE WIDESPREAD NATURE OF ALZHEIMER' S DISEASE PATHOLOGY, CELL-REPLACEMENT STRATEGIES HAVE BEEN VIEWED AS AN INCREDIBLY CHALLENGING AND UNLIKELY TREATMENT APPROACH.

  • Neurological Disorder
  • United States
  • Athersys, Inc.
  • ISCC
  • Vericel Corporation